Vietnam’s
pharmaceutical industry is increasingly appealing to excited investors.
For example, in April local giant Hau Giang
Pharmaceutical Joint Stock Company broke ground on a $24 million drug
production plant in Tan Phu Thanh Industrial Zone in southern An Giang
province. The plant, with an annual capacity of three billion tablets, is
slated to come online in late 2012.
Later South Korea’s leading group Korea United
Pharma aired its long-term investment plan in Vietnam. The group will pump $5
million into expanding its drug production plant in southern Binh Duong
Industrial Zone whose construction began in late 2009. The plant currently
churns out products made from ginseng for export to over 30 countries around
the world.
Thomson Medical Centre, a big private
healthcare group based in Singapore, recently had a working session with
southern Ninh Thuan province to discus building a specialised hospital for
tumor treatment combined with nursing in the province.
According to centre chairman Hwee Tiong Yeo,
Ninh Thuan’s propitious geographical and natural conditions were ideal for
healthcare service and tourism promotion.
“Our group will soon embark on the project
once getting high investment incentives and support in legal setup from local
governments,” said the executive.
US-based AmeriSure and Hanoi-based Vimedimex
pharmaceutical group recently inked a cooperative deal under which Vimedimex
will act as AmeriSure’s exclusive distributor of drugs, medical equipment,
vitamins and supplements, and cosmetics in the Vietnamese market. Vimedimex
also acquires exclusive rights to market and sell these products in the ASEAN
region, China, Japan and South Korea. In exchange Vimedimex will get AmeriSure
support.
India-based Fortis Healthcare Group just
wrapped up the acquisition of 65 per cent stake in Ho Chi Minh City-based Hoan
My Medical Corporation at $64 million.
Ministry of Planning and Investment’s Foreign
Investment Agency statistics show that Vietnam was home to 75 foreign
healthcare projects valued over $1 billion as of July 2011.
However, most of these Vietnam-based factories
cannot turn out high-value drugs for specific treatment. That is why the
country spent $1 billion on drug imports each year.
The latest report by Business Monitor International,
a leading provider of forecasts covering 175 countries and 22 industry sectors,
reads that Vietnam ranked 13th out of 17 of the world’s fastest growing markets
for drug spending.
Hai Yen | vir.com.vn
Business & Investment Opportunities
YourVietnamExpert is a division of Saigon Business Corporation Pte Ltd, Incorporated in Singapore since 1994. As Your Business Companion, we propose a range of services in Consulting, Investment and Management, focusing three main economic sectors: International PR; Healthcare & Wellness;and Tourism & Hospitality. We also propose Higher Education, as a bridge between educational structures and industries, by supporting international programs. Sign up with twitter to get news updates with @SaigonBusinessC. Thanks.
No comments:
Post a Comment